Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients
暂无分享,去创建一个
C. Debenedetti | D. Brusoni | P. Agostoni | M. Contini | D. Magrí | C. Fiorentini | C. Vignati | E. Salvioni | A. Apostolo | P. Palermo | G. Cattadori | E. Gondoni | Chiara Debenedetti
[1] P. Agostoni,et al. Noninvasive Cardiac Output Measurement: A New Tool in Heart Failure , 2009, Cardiology.
[2] D. V. van Veldhuisen,et al. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis , 2009, Heart.
[3] I. Anand. Anemia and chronic heart failure implications and treatment options. , 2008, Journal of the American College of Cardiology.
[4] G. Filippatos,et al. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[5] S. Katz,et al. The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes , 2008, Heart Failure Reviews.
[6] P. Armstrong,et al. Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia , 2008, Circulation.
[7] P. Duarte,et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.
[8] C. Lang,et al. Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. , 2007, Journal of cardiac failure.
[9] P. Ponikowski,et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.
[10] J. Mitchell. Emerging role of anemia in heart failure. , 2007, The American journal of cardiology.
[11] P. Ponikowski,et al. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. , 2007, Journal of the American College of Cardiology.
[12] D. Silverberg,et al. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. , 2006, American heart journal.
[13] P. Ponikowski,et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia , 2006 .
[14] M. Cappellini,et al. Exercise capacity in patients with β‐thalassaemia intermedia , 2005 .
[15] K. Wasserman,et al. Work‐rate affects cardiopulmonary exercise test results in heart failure , 2005, European journal of heart failure.
[16] C. O'connor,et al. Anemia as a risk factor and therapeutic target in heart failure. , 2004, Journal of the American College of Cardiology.
[17] J. Cleland,et al. Are hematinic deficiencies the cause of anemia in chronic heart failure? , 2004, American heart journal.
[18] J. McMurray. What are the clinical consequences of anemia in patients with chronic heart failure? , 2004, Journal of cardiac failure.
[19] P. Ponikowski,et al. Effect of anemia on exercise tolerance in chronic heart failure in men. , 2003, The American journal of cardiology.
[20] Paul W Armstrong,et al. Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.
[21] C. Lang,et al. Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.
[22] G. Fonarow,et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.
[23] C. O'connor,et al. A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.
[24] K. Wasserman,et al. Non-invasive measurement of stroke volume during exercise in heart failure patients. , 2000, Clinical science.
[25] K. Wasserman,et al. Exercise-induced hemoconcentration in heart failure due to dilated cardiomyopathy. , 1999, The American journal of cardiology.
[26] M. Guazzi,et al. Contribution of PO2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure. , 1996, Journal of applied physiology.
[27] B. Whipp,et al. A new method for detecting anaerobic threshold by gas exchange. , 1986, Journal of applied physiology.
[28] William T. Abraham,et al. Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .
[29] M. Kruszewski,et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. , 2008, European heart journal.
[30] M. Cappellini,et al. Exercise capacity in patients with beta-thalassaemia intermedia. , 2005, British journal of haematology.